Business Description
Tikun Olam Cannbit Pharmaceuticals Ltd
ISIN : IL0010843675
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.24 | |||||
Equity-to-Asset | 0.32 | |||||
Debt-to-Equity | 1.27 | |||||
Debt-to-EBITDA | -1.07 | |||||
Interest Coverage | 6.7 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -1.36 | |||||
Beneish M-Score | -5.89 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | -26.7 | |||||
3-Year FCF Growth Rate | 10.8 | |||||
3-Year Book Growth Rate | -15.4 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 16.39 | |||||
9-Day RSI | 24.93 | |||||
14-Day RSI | 31.09 | |||||
6-1 Month Momentum % | -2.14 | |||||
12-1 Month Momentum % | 3.69 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.6 | |||||
Quick Ratio | 0.48 | |||||
Cash Ratio | 0.16 | |||||
Days Inventory | 79.58 | |||||
Days Sales Outstanding | 65.8 | |||||
Days Payable | 31.57 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -25.5 | |||||
Shareholder Yield % | 6.35 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -13.92 | |||||
Operating Margin % | 32.61 | |||||
Net Margin % | -117.64 | |||||
FCF Margin % | 9.9 | |||||
ROE % | -130.93 | |||||
ROA % | -69.43 | |||||
ROIC % | 21.26 | |||||
ROC (Joel Greenblatt) % | -162.12 | |||||
ROCE % | -113.73 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.53 | |||||
PB Ratio | 1.93 | |||||
Price-to-Free-Cash-Flow | 4.4 | |||||
Price-to-Operating-Cash-Flow | 4.33 | |||||
EV-to-EBIT | -0.77 | |||||
EV-to-EBITDA | -2.32 | |||||
EV-to-Revenue | 0.89 | |||||
EV-to-FCF | 11.04 | |||||
Earnings Yield (Greenblatt) % | -128.52 | |||||
FCF Yield % | 16.98 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Tikun Olam Cannbit Pharmaceuticals Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₪) | 42.546 | ||
EPS (TTM) (₪) | -0.88 | ||
Beta | 0 | ||
Volatility % | 65.3 | ||
14-Day RSI | 31.09 | ||
14-Day ATR (₪) | 0.02898 | ||
20-Day SMA (₪) | 0.3667 | ||
12-1 Month Momentum % | 3.69 | ||
52-Week Range (₪) | 0.23 - 0.566 | ||
Shares Outstanding (Mil) | 84.96 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Tikun Olam Cannbit Pharmaceuticals Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Tikun Olam Cannbit Pharmaceuticals Ltd Stock Events
Event | Date | Price(₪) | ||
---|---|---|---|---|
No Event Data |
Tikun Olam Cannbit Pharmaceuticals Ltd Frequently Asked Questions
What is Tikun Olam Cannbit Pharmaceuticals Ltd(XTAE:TKUN)'s stock price today?
When is next earnings date of Tikun Olam Cannbit Pharmaceuticals Ltd(XTAE:TKUN)?
Does Tikun Olam Cannbit Pharmaceuticals Ltd(XTAE:TKUN) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |